Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Urinary tract infection
Clinical narrative: STIGMATISM IN EYES; ITCHING AT INJECTION SITE; JOINT PAIN; SWEATY; SORE/IT WAS LIKE INSIDE OF BONES HURT; FELT LIKE A MILDER VERSION OF THE COVID JUST LIKE THE FLU; URINARY TRACT INFECTION; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (SWEATY), ASTIGMATISM (STIGMATISM IN EYES), URINARY TRACT INFECTION (URINARY TRACT INFECTION), BONE PAIN (SORE/IT WAS LIKE INSIDE OF BONES HURT) and INFLUENZA LIKE ILLNESS (FELT LIKE A MILDER VERSION OF THE COVID JUST LIKE THE FLU) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    Previously administered products included for Drug use for unknown indication: CECLOR. Past adverse reactions to the above products included No adverse event with CECLOR. Concurrent medical conditions included Abstains from alcohol, Non-smoker, Sulfonamide allergy (MANIFESTED BY RASH), Drug allergy (MANIFESTED BY RASH) and Crohn's disease. Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA) for Neuropathy, PROMETHAZINE for Vomiting and Nausea.   In August 2020, the patient ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to 80 milligram every two weeks. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. In September 2020, the patient experienced URINARY TRACT INFECTION (URINARY TRACT INFECTION). In 2021, the patient experienced HYPERHIDROSIS (SWEATY), BONE PAIN (SORE/IT WAS LIKE INSIDE OF BONES HURT) and INFLUENZA LIKE ILLNESS (FELT LIKE A MILDER VERSION OF THE COVID JUST LIKE THE FLU). On an unknown date, the patient experienced ASTIGMATISM (STIGMATISM IN EYES), INJECTION SITE PRURITUS (ITCHING AT INJECTION SITE) and ARTHRALGIA (JOINT PAIN). The patient was treated with MAGNESIUM CITRATE at an unspecified dose and frequency; MACROGOL 3350 (MIRALAX) at an unspecified dose and frequency and AZITHROMYCIN (AZO) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (SWEATY), ASTIGMATISM (STIGMATISM IN EYES), BONE PAIN (SORE/IT WAS LIKE INSIDE OF BONES HURT), INFLUENZA LIKE ILLNESS (FELT LIKE A MILDER VERSION OF THE COVID JUST LIKE THE FLU) and ARTHRALGIA (JOINT PAIN) outcome was unknown and URINARY TRACT INFECTION (URINARY TRACT INFECTION) and INJECTION SITE PRURITUS (ITCHING AT INJECTION SITE) had not resolved.            No relevant concomitant medications were reported.   The reporter's causality for the events of sweaty, stigmatism in eyes, joint pain, urinary tract infection, itching at injection site, sore/it was like inside of bones hurt, and after getting the covid vaccine felt like a milder version of the covid just like the flu with humira was not provided.  No treatment information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-623731.